Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03728972
What this trial is testing

Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Who this might be right for
NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis)NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)
Memorial Sloan Kettering Cancer Center 19
Early research (Phase 1)Study completedNCT01147991
What this trial is testing

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Who this might be right for
Gastric CancerHead and Neck CancerLymphoma+2 more
Cancer Research UK 16
Early research (Phase 1)Active Not RecruitingNCT02287311
What this trial is testing

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

Who this might be right for
Hodgkin DiseaseNon-Hodgkin LymphomaSevere Chronic Active Epstein Barr Virus+3 more
Baylor College of Medicine 38
Testing effectiveness (Phase 2)WithdrawnNCT00387530
What this trial is testing

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer

Who this might be right for
Gastric CancerHead and Neck CancerLymphoma+1 more
University of California, San Diego